Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

NCT05724121 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT05724121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05724121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2023
Completion date
April 8, 2027
Enrollment
135 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrhythmias, chronic lymphocytic leukemia (cll), hematologic malignancies, mantle cell lymphoma, sudden cardiac death, waldenstr(sqrroot)(delta)m s macroglobulinemia